5R01AG066707-04 |
2023 |
None |
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease |
5R01AG066707-03 |
2022 |
$771366 |
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for AlzheimerÂ’s Disease |
5R01AG066707-02 |
2021 |
$663720 |
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for AlzheimerÂ’s Disease |
1R01AG066707-01 |
2020 |
$634650 |
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimer’s Disease |
3R01AG066707-01S1 |
2020 |
$395914 |
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimer's Disease |